Technical Analysis for AURA - Aura Biosciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
20 DMA Support | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
BB Squeeze Started | Range Contraction | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
50 DMA Resistance | Bearish | -0.40% | |
Crossed Above 20 DMA | Bullish | -0.40% | |
Pocket Pivot | Bullish Swing Setup | -0.40% | |
Gapped Up | Strength | -0.40% |
Alert | Time |
---|---|
Gap Up Closed | about 17 hours ago |
Gap Up Partially Closed | about 17 hours ago |
50 DMA Resistance | about 17 hours ago |
10 DMA Resistance | about 17 hours ago |
Down 3% | about 17 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.5 |
52 Week Low | 5.9906 |
Average Volume | 190,717 |
200-Day Moving Average | 8.61 |
50-Day Moving Average | 7.61 |
20-Day Moving Average | 7.39 |
10-Day Moving Average | 7.53 |
Average True Range | 0.40 |
RSI (14) | 50.25 |
ADX | 18.44 |
+DI | 28.41 |
-DI | 15.63 |
Chandelier Exit (Long, 3 ATRs) | 6.90 |
Chandelier Exit (Short, 3 ATRs) | 8.08 |
Upper Bollinger Bands | 7.87 |
Lower Bollinger Band | 6.91 |
Percent B (%b) | 0.61 |
BandWidth | 13.05 |
MACD Line | -0.03 |
MACD Signal Line | -0.05 |
MACD Histogram | 0.0165 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 8.58 | ||||
Resistance 3 (R3) | 8.62 | 8.29 | 8.40 | ||
Resistance 2 (R2) | 8.29 | 8.02 | 8.28 | 8.34 | |
Resistance 1 (R1) | 7.90 | 7.85 | 7.74 | 7.86 | 8.28 |
Pivot Point | 7.57 | 7.57 | 7.49 | 7.56 | 7.57 |
Support 1 (S1) | 7.18 | 7.30 | 7.02 | 7.14 | 6.72 |
Support 2 (S2) | 6.85 | 7.13 | 6.84 | 6.66 | |
Support 3 (S3) | 6.46 | 6.85 | 6.60 | ||
Support 4 (S4) | 6.42 |